Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 60 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Georgianos, Panagiotis I [Clear All Filters]
Albuminuria and cardiorenal risk..
Curr Opin Cardiol.
(2023). Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?.
Eur J Clin Invest. 53(2), e13864.
(2023). Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis..
Nephrol Dial Transplant. 38(1), 203-211.
(2023). Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?.
Expert Opin Pharmacother.
(2023). Therapeutic Advances in Diabetic Kidney Disease..
Int J Mol Sci. 24(3),
(2023). Which blood pressure threshold indicates a therapeutic benefit for patients with chronic kidney disease?.
Hypertens Res. 46(4), 890-892.
(2023). Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology..
Diagnostics (Basel). 12(12),
(2022). The interaction of estimated glomerular filtration rate with circadian blood pressure variation: do not forget the impact of albuminuria..
J Hypertens. 40(7), 1432-1433.
(2022). Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis..
Am J Hypertens. 35(11), 918-922.
(2022). Prevalence, recurrence and seasonal variation of hyperkalemia among patients on hemodialysis..
Int Urol Nephrol. 54(9), 2327-2334.
(2022). VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial..
PLoS One. 17(8), e0273102.
(2022). 10-year-long survival in a PD patient with severe calcifying encapsulating peritoneal sclerosis treated with tamoxifen: a case-report..
BMC Nephrol. 21(1), 110.
(2020). Blood pressure targets in patients with chronic kidney disease: A critical evaluation of clinical-trial evidence and guideline recommendations..
J Clin Hypertens (Greenwich). 22(5), 924-928.
(2020). Eating during the Hemodialysis Session: A Practice Improving Nutritional Status or a Risk Factor for Intradialytic Hypotension and Reduced Dialysis Adequacy?.
Nutrients. 12(6),
(2020). Prevalence and control of hypertension among patients on haemodialysis..
Eur J Clin Invest. 50(10), e13292.
(2020).
(2020). Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab..
Case Rep Nephrol. 2019, 3614980.
(2019). Assessment and Management of Hypertension among Patients on Peritoneal Dialysis..
Clin J Am Soc Nephrol. 14(2), 297-305.
(2019). Clinic and Home Blood Pressure Monitoring for the Detection of Ambulatory Hypertension Among Patients on Peritoneal Dialysis..
Hypertension. 74(4), 998-1004.
(2019). Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic Stroke..
Int J Hypertens. 2019, 9830295.
(2019). Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions..
J Clin Hypertens (Greenwich). 21(2), 249-251.
(2019). Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses..
J Clin Hypertens (Greenwich). 21(7), 919-921.
(2019). SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?.
Curr Med Chem. 26(29), 5564-5578.
(2019). Accuracy of a Newly-Introduced Oscillometric Device for the Estimation of Arterial Stiffness Indices in Patients on Peritoneal Dialysis: A Preliminary Validation Study..
Adv Perit Dial. 34(2018), 24-31.
(2018). Antihypertensive therapy in acute ischemic stroke: where do we stand?.
J Hum Hypertens. 32(12), 799-807.
(2018).